SEC Form 4 · accession 0001638599-17-000685

SELECTA BIOSCIENCES INC · SELB

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — COO and SVP, R*D

Period of report

Jul 3, 2017

Accepted (ET)

Jul 6, 2017 · 4:05 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001453687

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Stock	Jul 3, 2017	M	5,959	$2.77	A	7,565	D
Common Stock^F2	Jul 3, 2017	S	100	$19.74	D	7,465	D
Common Stock^F3	Jul 3, 2017	S	5,859	$19.0873	D	1,606	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Employee Stock Option (right to buy)^F4	$2.77	Jul 3, 2017	M	5,959	D	—	Jun 13, 2023	Common Stock	5,959	126	D

F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 21, 2016.
F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.72 to $19.76, inclusive. The reporting person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.
F3The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.605 to $19.40, inclusive. The reporting person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.
F4All shares underlying this option are fully vested.